ASTRAZENECA: JP Morgan still positive








Already positive on the record, research at JP Morgan and its analyst James Gordon still consider the title as a buying opportunity. The price target continues to be at 10,000 GBX.

Zonebourse with dpa-AFX Analyzer 2022

All the news on ASTRAZENECA PLC

Analyst Recommendations for ASTRAZENECA PLC

2022 turnover 43,806M

39,850M
2022 net result 5,482M

4,987M
Net debt 2022 22,954M

20,881M
PER 202236.0x
2022 return2.21%
Capitalization 206 billion
206 billion
188 billion
VE / CA 20225.23x
VE / CA 20234.78x
Number of employees83 100
Floating96.4%

Chart ASTRAZENECA PLC


Tough :

Period:




AstraZeneca PLC : Chart technical analysis AstraZeneca PLC |  Market area

Trends technical analysis ASTRAZENECA PLC

Short termMiddle termLong term
Trendsbullishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts25
Last Closing Price$133.05
Average price target$139.42
Deviation / Average Target4.79%

Officers and Directors




Source link -88